Pfizer

The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.

Data "shows the consequence of these vaccines and masks," said Dr. Fleming.

Her doctor told her a booster was "ill-advised."

The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer (PFE.N) and BioNTech's COVID-19 vaccine for children aged 5 to 11, making everyone in the country over the age of 5 eligible for a third shot.

Crenshaw financed by Boeing, Lockheed Martin, Raytheon, and more.

New hepatitis vaccine hit market in March—now CDC wants to remove "obstacle" of risk assessment before injecting patients with hepatitis vaccine.

Former Pfizer VP Michael Yeadon maintains that since the infection fatality ratio of COVID-19 has not been high, the vaccines should not have been mandated.

Peer-reviewed study shows antibody levels drop quickly to 19$ at weeks 12 to 14.

In this interview, return guest Stephanie Seneff, Ph.D., a senior research scientist at MIT for over five decades, discusses the COVID-19 vaccines.

The U.S. Food and Drug Administration’s (FDA) top vaccine official told a congressional committee on Friday that COVID-19 vaccines for kids under 6 will not have to meet the agency’s 50% efficacy threshold required to obtain Emergency Use Authorization (EUA).